Skip to main content

TRIAMCINOLONE ACETONIDE

Generic: Triamcinolone Acetonide

Verified·Apr 23, 2026
NDC
67877-251
RxCUI
1014314
Route
TOPICAL
ICD-10 indication
L30.9

Affordability Check

How much will you actually pay for TRIAMCINOLONE ACETONIDE?

In 30 seconds, see every legitimate way to afford TRIAMCINOLONE ACETONIDE — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About TRIAMCINOLONE ACETONIDE

What is this medication? Triamcinolone acetonide is a synthetic corticosteroid medication used to treat a wide range of inflammatory conditions. It works by suppressing the immune system and reducing the production of chemicals that cause swelling, redness, and itching. This versatile medication is prescribed in various forms depending on the condition being treated, including topical creams for skin issues like eczema, dental pastes for mouth sores, and injections for joint inflammation or severe allergic reactions. In addition to its topical and injectable uses, this medication is often utilized as a nasal spray to manage seasonal allergy symptoms. It helps provide relief from congestion, sneezing, and runny noses by calming the lining of the nasal passages. Because it is a strong steroid, patients should follow their doctors instructions carefully to avoid potential side effects such as skin thinning or systemic absorption. It is primarily intended for short-term or localized relief of inflammatory symptoms rather than a permanent cure for underlying conditions.

Copay & patient assistance

  • Patient Copay Amount: As little as $0
  • Maximum Annual Benefit Limit: Not Publicly Available
  • Core Eligibility Restrictions: Must have commercial insurance and coverage; not valid for patients covered by federal or state government programs (including Medicare, Medicaid, TRICARE, and Veterans Administration); must be 18 years of age or older; US residency required; residents of California, Massachusetts, Minnesota, and Rhode Island are not eligible.
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for TRIAMCINOLONE ACETONIDE. Official source: DailyMed (NLM) · Label effective Feb 14, 2024

Indications and usage
INDICATIONS & USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage and administration
DOSAGE & ADMINISTRATION Topical corticosteroids are generally applied to the affected area as a thin film two to four times daily for the 0.025% strength and two or three times daily for the 0.1% and 0.5% strength depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
Contraindications
CONTRAINDICATIONS Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Adverse reactions
ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.
Use in pregnancy
PREGNANCY CATEGORY C Corticosteroids are generally teratogenic in laboratory animals when administered systemically at relatively low dosage levels. The more potent corticosteroids have been shown to be teratogenic after dermal application in laboratory animals. There are no adequate and well-controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids. Therefore, topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Drugs of this class should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How TRIAMCINOLONE ACETONIDE appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

79%

4,358 of 5,509 plans

Most common tier

Tier 2

On 45% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)88
27%
Tier 2 (generic)148
45%
Tier 3 (preferred brand)90
27%
Tier 4 (non-preferred brand)3
1%

Step therapy: 0% of formularies

Quantity limits: 26% of formularies

Coverage breadth: 329 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Medicare Part D

Medicare Part D

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.